Mobius Medical Systems has announced that it has received FDA 510(k) clearance for its Mobius3D quality assurance software.
The software, which is used for treatment plan verification in radiation therapy, calculates 3D radiation dose based on previous plans and log data using an independently developed quality algorithm.
“Mobius3D is the result of several years of development and testing,” said company founder Nathan Childress, PhD, in a press release. “We are very pleased with the FDA clearance and look forward to showing clinicians in the U.S. the vast improvements Mobius3D provides in the safety and effectiveness of patient treatments.”
MobiusFX, an optional add-on for the system which utilizes the same collapsed-cone algorithm files to determine 3D dose delivered to the patient, was also included in the FDA clearance.